Translational Highlights in Breast and Ovarian Cancer 2019 - Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy.

Geburtshilfe Frauenheilkd · 2019 · PMC6924326 · PMID 31875860

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Overall, the study was negative, but a clear trend could be seen that pembrolizumab was superior to chemotherapy with increasing PD-L1 expression.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.